Regulation (EU) 2024/2699
Commission Implementing Regulation (EU) 2024/2699 of 18 October 2024 laying down, pursuant to Regulation (EU) 2021/2282 of the European Parliament and of the Council, detailed procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment and the Commission with the European Medicines Agency in the form of exchange of information as regards the joint clinical assessment of medicinal products and medical devices and in vitro diagnostic medical devices and as regards the joint scientific consultation on medicinal products and medical devices
- 1Subject matter
- 2Information exchange related to the planning and forecast of the joint clinical assessments and joint scient
- 3Information exchange related to the selection of medical devices and in vitro diagnostic medical devices for
- 4Information exchange with the Coordination Group and its EHT Subgroup and JCA Subgroup
- 5Information exchange related to the identification of individual experts in the context of joint clinical as
- 6Information exchange on horizontal scientific and technical matters related to joint clinical assessment and
- 7Secure exchange of information
- 8Protection of confidential information
- 9Failure to respect the obligations of professional secrecy
- 10Entry into force
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).